H3D
@H3D_UCT
H3D is the first and only centre of its kind on the African continent, an integrated drug discovery and development centre with TB, malaria and AMR platforms
🎉 Wrapping Up 2024 with Gratitude and Joy 🎉 As 2024 ends, we reflect on what a wonderfully busy and fulfilling year it has been for everyone @H3D. From all of us @H3D, we wish you a happy and joyous holiday season! Here’s to a bright and inspiring year ahead! ✨




Academic–industry #collaborations are a powerful catalyst for pharmaceutical innovation. Drawing on experiences at H3D, Winks et al. explore the benefits and challenges in the context of #drugdiscovery in this ACS Med. Chem. Lett. Viewpoint 💊 pubs.acs.org/doi/full/10.10…
Now out in #JMedChem! 💊 We report SARs for sapanisertib, identifying analogues with improved safety profiles and dual inhibitory activities against high-value Plasmodium targets PI4Kβ and PKG; a selected compound achieved an in vivo proof-of-concept 🐭 pubs.acs.org/doi/10.1021/ac…
📣 New in #AngewChemIntEd: Woodland and Coertzen et al. show that the anticancer kinase inhibitor AZD0156 is a potent inhibitor of Plasmodium PI4Kβ and is an attractive candidate for medicinal chemistry optimisation against malaria 👨🔬 @UCTIDM @UCT_news onlinelibrary.wiley.com/doi/10.1002/an…
In #JMedChem, we report a spiroindoline series with high sp3 character and potent activity against drug-resistant #malaria parasites. SAR explorations yielded a novel pyridylspiroindoline frontrunner (50) with promise for further optimisation 🔄 @UCTIDM pubs.acs.org/doi/full/10.10…
Appearing earlier this month in #JMedChem, we report the design, synthesis and evaluation of novel mercapto-3-phenylpropanoyl dipeptides as dual angiotensin-converting enzyme C−domain-selective/neprilysin inhibitors: pubs.acs.org/doi/10.1021/ac… @UCT_news @UCTIDM
Despite the use of mefloquine in malaria prophylaxis and treatment, its metabolism is not completely understood. In our latest publication in #DrugMetabDispos, Cloete et al. identify CYP1A2 as a key enzyme involved in mefloquine metabolism: sciencedirect.com/science/articl…
Identification of novel drug targets is a key component of modern #drugdiscovery 💡 We were part of a team that systematically assessed the P. falciparum genome to identify a list of 27 high-priority antimalarial targets. Read more in npj Drug Discovery! nature.com/articles/s4438…
Just out in #ACSMedChemLett: Ishmail et al. report the synthesis and SAR studies of acyl-thiourea platinum(II) complexes, yielding analogues with dual-stage antiplasmodium activity as part of the search for new antimalarials 💊 @ACSBioMed @UCT_news @UCTIDM pubs.acs.org/doi/full/10.10…
📣 Hot off the press! A Viewpoint article appearing in the esteemed journal @angew_chem written by @DrClintVeale, @jgwoodland, @Kathryn_Wicht and @Kelly_Chibale, entitled "Chemistry as a Catalyst for Transforming the Health and Wealth of South Africa" 🇿🇦 onlinelibrary.wiley.com/doi/10.1002/an…
Our contributions to a manuscript appearing in @BiochemistryACS show that C-terminal amidation of AamAP1-Lys results in an analogue that is significantly more active against Gram-negative pathogens, with improved selectivity 🧫 pubs.acs.org/doi/10.1021/ac… @UCT_news @UCTIDM
Our latest article, appearing in #FEBSLett, elucidates the molecular basis of inhibition of human angiotensin-1 converting enzyme (ACE), an important target for hypertension and inflammation, by a series of diprolyl-derived compounds: febs.onlinelibrary.wiley.com/doi/full/10.11… 🧬 @UCT_news @UCTIDM
Appearing in the European Journal of Medicinal Chemistry, our latest publication by Dziwornu and Attram et al. reports the antischistosomal potential of a new series of compounds derived from the privileged benzimidazole scaffold: doi.org/10.1016/j.ejme… 🌍 @UCT_news @UCTIDM
Exciting Opportunity: Join @H3D_UCT as a Postdoc Fellow in Medicinal Chemistry @H3D_UCT is looking for talented postdoctoral fellows to contribute to cutting-edge research Closing Date: 10 Jan 2025 #PostDocOpportunity #MedicinalChemistry

In our latest #ACSMedChemLett, together with colleagues in Brazil, Sousa et al. describe the integration of virtual screening, synthesis and experimental validation to yield non-covalent inhibitors of SARS-CoV-2 PLpro: pubs.acs.org/doi/10.1021/ac… @UCT_news @UCTIDM 💡
Recently published in #NatCommun, Naude et al. shine light on how lipoidal uptake of antimalarial compounds influences their asexual blood stage versus transmission-blocking capabilities: nature.com/articles/s4146… @UCT_news @UCTIDM 🦟
Prof. @kellychibale, a leading scientist on the continent, believes that Africa, the cradle of humanity, holds keys to groundbreaking scientific advances. See the full article here: theguardian.com/global-develop… #Innovation #GuardianNewspaper #RoyalSociety #Africa
H3D would like to extend a huge congratulations to our Director, @KellyChibale for being elected as one of the 10 international members of the prestigious United States @theNAMedicine 👏 Full press release here: nam.edu/national-acade… #NAM #PressRelease #Groundbreakingresearch
UPDATE📢 The #DrugDiscoveryAfrica 2025 Abstract submission deadline: 27th October 2024 All the details are on our website 👇: lnkd.in/ebRzu8fe The organising committee is looking forward to receiving your abstract. #AbstractSubmissions #DrugDiscoveryAfrica

Reminder to sign up for the #H3D Open Day this week Saturday, 19 October 2024 at 9h00am - 13h00pm! If you're studying science in the Western Cape, don't miss the chance to tour our labs and learn about exciting careers in #DrugDiscovery😀
